Literature DB >> 15341186

Modulation of retinal dopaminergic cells by nitric oxide. A protective effect on NMDA-induced retinal injury.

Yasushi Kitaoka1, Toshio Kumai.   

Abstract

Nitric oxide (NO) may play an important role in regulating retinal neuronal survival. While the precise impact of NO mechanisms on retinal neurons remains to be elucidated, it has been reported that low doses of NO may have a neuroprotective effect against N-methyl-D-aspartate (NMDA)-induced retinal neurotoxicity. Dopamine has also been recognized to have neuroprotective actions. Retinal dopaminergic cells can be detected by the immunohistochemical staining of tyrosine hydroxylase (TH), the rate-limiting enzyme in dopamine synthesis. We observed that NMDA dramatically decreased in TH immunostaining at the junction between the inner nuclear layer and inner plexiform layer, and that this reduction in immunostaining was attenuated by the co-injection of NOC 18, an NO donor. Thus, the current review focused on the NO-dopamine interactions in the retinal neuroprotection.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15341186

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  3 in total

1.  NO donors inhibit Na,K-ATPase activity by a protein kinase G-dependent mechanism in the nonpigmented ciliary epithelium of the porcine eye.

Authors:  Mohammad Shahidullah; Nicholas A Delamere
Journal:  Br J Pharmacol       Date:  2006-06-12       Impact factor: 8.739

2.  Dopamine D2 Receptor-Mediated Modulation of Rat Retinal Ganglion Cell Excitability.

Authors:  Ning Yin; Yu-Long Yang; Shuo Cheng; Hong-Ning Wang; Xin Hu; Yanying Miao; Fang Li; Zhongfeng Wang
Journal:  Neurosci Bull       Date:  2019-10-12       Impact factor: 5.203

3.  Melanopsin ganglion cells are the most resistant retinal ganglion cell type to axonal injury in the rat retina.

Authors:  Luis Pérez de Sevilla Müller; Allison Sargoy; Allen R Rodriguez; Nicholas C Brecha
Journal:  PLoS One       Date:  2014-03-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.